Jump to top menu Jump to main menu Jump to content
Afbeelding man als foto ontbreekt

R. (Ruben) Malmberg

PhD student

  • Department
  • Hospital Pharmacy
  • Focus area
  • Hospital Pharmacy and Medical Oncology



Ruben is currently working on his PhD research project on advances in cost-effective oncology care.

Field(s) of expertise

  • Oncology.

Education and career

  • PharmD.


  • Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model. PMID: 25697412
  • Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'. PMID: 32854077
  • Cox, J. M., van Doorn, L., Malmberg, R., Oomen-de Hoop, E., Bosch, T. M., van den Bemt, P. M. L. A. et al. The added value of H2-antagonists in premedication regimens during paclitaxel treatment. Br. J. Cancer (2021)

My Groups